Brought to you by 
Codiak BioSciences launches; gets $31mm through Series A round
19 Sep 2017
Executive Summary
Codiak BioSciences Inc. (exosome-based therapies and diagnostics) launched and $31mm in Series A funding from Arch Venture Partners, Flagship Ventures, Fidelity Management & Research, Alaska Permanent Fund, Alexandria Venture Investments, and seven other undisclosed backers.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Codiak BioSciences launches; gets $31mm through Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice